In GBM-NS models with low CSPG4 expression, microglial cells surrounding the tumor induced CSPG4 upregulation on the tumor cell surface by releasing TNF-α, thereby enhancing the therapeutic efficacy of CAR-T cells [139]. The gene discussed is CSPG4; the disease is glioblastoma.